<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-04T20:22:15+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药不能停！地方集采速度要加快了</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/-sTL48RQXMXLrVZVX3umbw</id>
    <link href="https://mp.weixin.qq.com/s/-sTL48RQXMXLrVZVX3umbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】 7款超10亿重磅注射剂过评，豪森「培美曲塞二钠」、扬子江「紫杉醇」、奥赛康「兰索拉唑」......</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Q7ceQx7f36Nj0jOHBx8Lxw</id>
    <link href="https://mp.weixin.qq.com/s/Q7ceQx7f36Nj0jOHBx8Lxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辅仁药业所持股份100%被冻结，借款余额减少下，日子仍旧难过</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yIM1p7r9ugVyolOulZu6CA</id>
    <link href="https://mp.weixin.qq.com/s/yIM1p7r9ugVyolOulZu6CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企注意！33个大品种带量采购，申报开始</title>
    <updated>2020-12-04T17:11:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/IPfPocpuBmFdnCB5CdCpwQ</id>
    <link href="https://mp.weixin.qq.com/s/IPfPocpuBmFdnCB5CdCpwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE药审分析， BET、GCS、BTK 等靶点新药申报受理，贝达、复星、赛诺菲…</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/1SZi4pS1_MW8hcwEhrHfHg</id>
    <link href="https://mp.weixin.qq.com/s/1SZi4pS1_MW8hcwEhrHfHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>突破历史！恒瑞新药报产与临床获批双高，4款1类新药上市在即</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/4rulrVW8OQQApWD0Ew71tQ</id>
    <link href="https://mp.weixin.qq.com/s/4rulrVW8OQQApWD0Ew71tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏：开展三款新冠疫苗采购，国药、科兴...</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/9xf4aeO4d_ChQ-quLxh1pg</id>
    <link href="https://mp.weixin.qq.com/s/9xf4aeO4d_ChQ-quLxh1pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫苗行业突发重大利好，跨年行情或将迎来国产“新冠疫苗”？</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/qGuouqp3xmznTRBhWldC7g</id>
    <link href="https://mp.weixin.qq.com/s/qGuouqp3xmznTRBhWldC7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】2020药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-03T17:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/P1LqPboA9p8CTOyEUyQRtw</id>
    <link href="https://mp.weixin.qq.com/s/P1LqPboA9p8CTOyEUyQRtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年海外龙头药企收入排行：PD-1收入最高，PARP增速最快！</title>
    <updated>2020-12-02T17:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/Hbczq47mWJNXdNWHqSiH8Q</id>
    <link href="https://mp.weixin.qq.com/s/Hbczq47mWJNXdNWHqSiH8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>健之佳上市首日，开盘涨幅44%！蓝波等了22年</title>
    <updated>2020-12-02T17:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/imys9A5TSU_BRpJ9qDpa0A</id>
    <link href="https://mp.weixin.qq.com/s/imys9A5TSU_BRpJ9qDpa0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采完成率翻倍，回款金额46832.22万元，回款比例达92.6%</title>
    <updated>2020-12-02T17:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/4d95gfPaR2t8c69hYxTVeg</id>
    <link href="https://mp.weixin.qq.com/s/4d95gfPaR2t8c69hYxTVeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名药企，销售团队重大调整</title>
    <updated>2020-12-02T17:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/u8JfP5WUwCChDKShNRZOqw</id>
    <link href="https://mp.weixin.qq.com/s/u8JfP5WUwCChDKShNRZOqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>对话专家：打破高端制剂研发窘境，其「难点」何在？</title>
    <updated>2020-12-01T17:15:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/CBqxBFqxyxnu9KgUfhTM0w</id>
    <link href="https://mp.weixin.qq.com/s/CBqxBFqxyxnu9KgUfhTM0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球TOP20药企Q3市值仅一半实现正增长！辉瑞、第一三共增长超10%</title>
    <updated>2020-12-01T17:15:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/p_kkYpqMsxusEZS_Z_v2HQ</id>
    <link href="https://mp.weixin.qq.com/s/p_kkYpqMsxusEZS_Z_v2HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中成药纳入集中带量采购，增加基药比例？</title>
    <updated>2020-12-01T17:15:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/LEtkcn8CEyFrkSrNtE8JtQ</id>
    <link href="https://mp.weixin.qq.com/s/LEtkcn8CEyFrkSrNtE8JtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四轮国采，这些品种或入选（附名单）</title>
    <updated>2020-12-01T17:15:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/rTnLUi-vlZYezxV8Ba2Z3Q</id>
    <link href="https://mp.weixin.qq.com/s/rTnLUi-vlZYezxV8Ba2Z3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020医保谈判在即，药企如何做好战略变革？</title>
    <updated>2020-11-30T18:09:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/gU34tAD2UJYsA0PJksMd7Q</id>
    <link href="https://mp.weixin.qq.com/s/gU34tAD2UJYsA0PJksMd7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从DRG到DIP，精细化管理触发点在哪儿？</title>
    <updated>2020-11-30T18:09:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/bTpYodb8uFI0mzxzCDIgaQ</id>
    <link href="https://mp.weixin.qq.com/s/bTpYodb8uFI0mzxzCDIgaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月上市药品分析：新增批文27个，17个医保药品，5个独家品种！苑东生物、正大天晴…</title>
    <updated>2020-11-30T18:09:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/mpntPDY_tIVhuKa-G6Hm0A</id>
    <link href="https://mp.weixin.qq.com/s/mpntPDY_tIVhuKa-G6Hm0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>